SQZ Biotechnologies

NYSE: SQZ · Real-Time Price · USD
0.43
0.16 (59.26%)
At close: Jul 03, 2023, 7:00 PM

SQZ Biotechnologies Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
21.03M 27.1M
Cost of Revenue
n/a n/a
Gross Profit
21.03M 27.1M
Operating Income
-80.68M -68.77M
Interest Income
1.22M 36K
Pretax Income
-79.46M -68.74M
Net Income
-78.24M -68.7M
Selling & General & Admin
26.32M 25.72M
Research & Development
70.98M 70.15M
Other Expenses
-449K -8K
Operating Expenses
96.85M 95.87M
Interest Expense
9.72M n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
96.85M 95.87M
Income Tax Expense
-1.22M -36K
Shares Outstanding (Basic)
28.81M 27.58M
Shares Outstanding (Diluted)
28.81M 27.58M
EPS (Basic)
-2.72 -2.49
EPS (Diluted)
-2.72 -2.49
EBITDA
-59.28M -57.74M
EBIT
-69.75M n/a
Depreciation & Amortization
21.4M 11.03M